<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM">
      <PMID Version="2">35495962</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">2049-0801</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>78</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine and surgery (2012)</Title>
          <ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A novel case of lupus nephritis and mixed connective tissue disorder in a COVID-19 patient.</ArticleTitle>
        <Pagination>
          <StartPage>103653</StartPage>
          <MedlinePgn>103653</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">103653</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amsu.2022.103653</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Mixed connective tissue disease (MCTD) is a rare autoimmune condition characterized by Scleroderma, Polymyositis, and Systemic Lupus Erythematous (SLE). Though a possible relationship between COVID-19 and autoimmune diseases has been recently reported, its pathophysiological mechanism behind flares in Lupus Nephritis (LN), a complication of SLE, remains unknown.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="UNASSIGNED">A 22-year-old COVID-19 positive female presented with anemia, bilateral pitting edema, periorbital swelling, and posterior cervical lymphadenitis. Further inspection revealed lower abdominal striae, hepatosplenomegaly, and hyperpigmented skin nodules. Complete blood counts showed elevated inflammatory markers and excessively high protein creatinine ratio. Antinuclear antibody titers were elevated (anti-smith and U1 small nuclear ribonucleoprotein) and Rheumatoid Factor was positive. She was diagnosed with MCTD associated with a flare of LN. To control her lupus flare, a lower dose of steroids was initially administered, in addition to oral hydroxychloroquine and intravenous cyclophosphamide. Her condition steadily improved and was discharged on oral steroid maintenance medication.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">We present a rare phenomenon of newly diagnosed LN, a complication of SLE, with MCTD in a PCR-confirmed COVID-19 patient. The diagnostic conundrum and treatment hurdles should be carefully addressed when patients present with lupus and COVID-19 pneumonia, with further exploration of the immuno-pathophysiology of COVID-19 infection in multi-systemic organ dysfunction in autoimmune disorders.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In COVID-19 patients with LN and acute renal injury, it is critical to promptly and cautiously treat symptomatic flares associated with autoimmune disorders such as SLE and MCTD that may have gone unnoticed to prevent morbidity from an additional respiratory infection.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Sajjad</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almas</LastName>
            <ForeName>Talal</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaidi</LastName>
            <ForeName>Ujala</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Farea</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaikh</LastName>
            <ForeName>Sufyan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaikh</LastName>
            <ForeName>Fathema</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tafveez</LastName>
            <ForeName>Rida</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arsalan</LastName>
            <ForeName>Maaz</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antony</LastName>
            <ForeName>Ishan</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antony</LastName>
            <ForeName>Meetty</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Jawaharlal Nehru Medical College, Belgaum, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tahir</LastName>
            <ForeName>Burhanuddin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aborode</LastName>
            <ForeName>Abdullahi T</ForeName>
            <Initials>AT</Initials>
            <AffiliationInfo>
              <Affiliation>Healthy Africans Platform, Research and Development, Ibadan, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Murtaza</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Dr. Ruth K.M. Pfau, Civil Hospital Karachi, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagarajan</LastName>
            <ForeName>Vikneswaran Raj</ForeName>
            <Initials>VR</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samy</LastName>
            <ForeName>Arjun</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alrawashdeh</LastName>
            <ForeName>Maen Monketh</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alkhattab</LastName>
            <ForeName>Maha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Galway University Hospital, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramjohn</LastName>
            <ForeName>Joshua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Sligo University Hospital, Sligo, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramjohn</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>University of Birmingham Medical School, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Helen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nawaz</LastName>
            <ForeName>Qassim Shah</ForeName>
            <Initials>QS</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Kashif Ahmad</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khullar</LastName>
            <ForeName>Shane</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>RCSI University of Medicine and Health Sciences, Dublin, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med Surg (Lond)</MedlineTA>
        <NlmUniqueID>101616869</NlmUniqueID>
        <ISSNLinking>2049-0801</ISSNLinking>
      </MedlineJournalInfo>
      <CoiStatement>N/A.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>46</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35495962</ArticleId>
        <ArticleId IdType="pmc">PMC9034828</ArticleId>
        <ArticleId IdType="doi">10.1016/j.amsu.2022.103653</ArticleId>
        <ArticleId IdType="pii">S2049-0801(22)00413-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Venables P.J. Mixed connective tissue disease. Lupus. 2006;15(3):132–137. doi: 10.1191/0961203306lu2283rr.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1191/0961203306lu2283rr</ArticleId>
            <ArticleId IdType="pubmed">16634365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maidhof W., Hilas O. Lupus: an overview of the disease and management options. P T. 2012;37(4):240–249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3351863</ArticleId>
            <ArticleId IdType="pubmed">22593636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diagnosing and treating lupus | CDC. Cdc.gov. 2022. https://www.cdc.gov/lupus/basics/diagnosing.htm Retrieved 4 February 2022, from.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId>
            <ArticleId IdType="pubmed">32091533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavascki A.P., Falci D.R. Clinical characteristics of covid-19 in China. N. Engl. J. Med. 2020;382:1859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32220202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan I., Sarwar A., Ahmed Z. Atypical case of COVID-19 associated Kawasaki disease in an eight-year-old Pakistani boy. Cureus. 2020;12 doi: 10.7759/cureus.10670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.10670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh R., Kashyap R., Hutton A., Sharma M., Surani S. A review of cardiac complications in coronavirus disease 2019. Cureus. 2020;12 doi: 10.7759/cureus.8034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.8034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon T., Gandhi S.A.Q., Tariq W., et al.  Impact of chronic kidney disease on severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Cureus. 2021;13 doi: 10.7759/cureus.14279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.14279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon T., Sharma R., Kataria S., et al.  The association of acute kidney injury with disease severity and mortality in COVID- 19: a systematic review and meta-analysis. Cureus. 2021;13 doi: 10.7759/cureus.13894.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.13894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh R., Shiza S.T., Saadat R., Dawe M., Rehman U. Association of Guillain-Barre syndrome with COVID- 19: a case report and literature review. Cureus. 2021;13 doi: 10.7759/cureus.13828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.13828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joo Y.B., Lim Y.H., Kim K.J., Park K.S., Park Y.J. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res. Ther. 2019;21:199. doi: 10.1186/s13075-019-1977-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13075-019-1977-9</ArticleId>
            <ArticleId IdType="pmc">PMC6716891</ArticleId>
            <ArticleId IdType="pubmed">31470887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gartshteyn Y., Askanase A.D., Schmidt N.M., et al.  COVID-19 and systemic lupus erythematosus: a case series. Lancet Rheumatol. 2020;2:e452–e454. doi: 10.1016/S2665-9913(20)30161-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2665-9913(20)30161-2</ArticleId>
            <ArticleId IdType="pmc">PMC7250558</ArticleId>
            <ArticleId IdType="pubmed">32835249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalid M., Rogers S., Fatima A., et al. July 02  A flare of systemic lupus erythematosus disease after COVID-19 infection: a case of lupus cerebritis. Cureus. 2021;13(7) doi: 10.7759/cureus.16104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.16104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agha R.A., Franchi T., Sohrabi C., Mathew G., for the SCARE Group  The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33181358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kreuter A., Licciardi-Fernandez M.J., Burmann S.N., Burkert B., Oellig F., Michalowitz A.L. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination. Clin. Exp. Dermatol. 2022;47(1):161–163. doi: 10.1111/ced.14858. Jan. Epub 2021 Sep 13. PMID: 34291477; PMCID: PMC8444843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ced.14858</ArticleId>
            <ArticleId IdType="pmc">PMC8444843</ArticleId>
            <ArticleId IdType="pubmed">34291477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brockman T., Hernandez L., Mehta T., Thapa B. Pericarditis as a secondary complication of COVID-19 in a renal transplant patient. Wis. Med. J. 2021;120(4):313–315. Dec. PMID: 35025181.</Citation>
        </Reference>
        <Reference>
          <Citation>Muyldermans A., Maes P., Wawina-Bokalanga T., Anthierens T., Goldberg O., Bartiaux M., Soetens O., Wybo I., Van den Wijngaert S., Piérard D. Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report. J. Med. Case Rep. 2021;15(1):572. doi: 10.1186/s13256-021-03159-9. Nov 26. PMID: 34836543; PMCID: PMC8620303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13256-021-03159-9</ArticleId>
            <ArticleId IdType="pmc">PMC8620303</ArticleId>
            <ArticleId IdType="pubmed">34836543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roncati L., Corsi L., Barbolini G. Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome. J. Thromb. Thrombolysis. 2021;52(4):1043–1046. doi: 10.1007/s11239-021-02444-0. Nov. Epub 2021 Apr 12. PMID: 33844151; PMCID: PMC8040358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11239-021-02444-0</ArticleId>
            <ArticleId IdType="pmc">PMC8040358</ArticleId>
            <ArticleId IdType="pubmed">33844151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patil S., Patil A. Systemic lupus erythematosus after COVID-19 vaccination: acase report. J. Cosmet. Dermatol. 2021;20(10):3103–3104. doi: 10.1111/jocd.14386. Oct. Epub 2021 Aug 21. PMID: 34418261; PMCID: PMC8661983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jocd.14386</ArticleId>
            <ArticleId IdType="pmc">PMC8661983</ArticleId>
            <ArticleId IdType="pubmed">34418261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nespola M., Sirignano P., Fermani N., Battocchio C., Tosti F., Pranteda C., Taurino M. Treatment-resistant acute upper limb Ischemia in a patient with systemic lupus erythematous and concomitant SARS-CoV-2 infection: a case report. Ann. Vasc. Surg. 2021;76:289–292. doi: 10.1016/j.avsg.2021.05.012. Oct. Epub 2021 Jun 25. PMID: 34182111; PMCID: PMC8233045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.avsg.2021.05.012</ArticleId>
            <ArticleId IdType="pmc">PMC8233045</ArticleId>
            <ArticleId IdType="pubmed">34182111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karsulovic C., Hojman L.P., Seelmann D.L., Wurmann P.A. Diffuse lymphadenopathy syndrome as a flare-up manifestation in lupus and mixed connective tissue disease following mild COVID-19. Am J Case Rep. 2021;22 doi: 10.12659/AJCR.932751. Sep. 10. PMID: 34504052; PMCID: PMC8445385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/AJCR.932751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yusuf A.S., Cheong X.K., Rozita M., Periyasamy P., Ruslinda M. A case of lupus nephritis flare-up in severe COVID-19 infection. Med. J. Malaysia. 2021;76(5):757–761. Sep. PMID: 34508391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34508391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hali F., Jabri H., Chiheb S., Hafiani Y., Nsiri A. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: a new case report. Int. J. Dermatol. 2021;60(8):1030–1031. doi: 10.1111/ijd.15592. Aug. Epub 2021 Apr 17. PMID: 33864388; PMCID: PMC8251349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijd.15592</ArticleId>
            <ArticleId IdType="pmc">PMC8251349</ArticleId>
            <ArticleId IdType="pubmed">33864388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Aoud S., Morin C., Lorriaux P., Obert J., Sorial D., Chaabouni T., Thomas L. COVID-19 presenting as lupus erythematosus-like syndrome. Disaster Med. Public Health Prep. 2021;15(4):e12–e15. doi: 10.1017/dmp.2020.358. Aug. Epub 2020 Sep 10. PMID: 32907688; PMCID: PMC7642503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/dmp.2020.358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahramnezhad F., Ghorbani B., Ghaedrahamt M., Jamaati H. Coronavirus- disease-2019-induced antiphospholipid-like syndrome: a case report. J. Med. Case Rep. 2021;15(1):408. doi: 10.1186/s13256-021-02966-4. Jul 29. PMID: 34321077; PMCID: PMC8318629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13256-021-02966-4</ArticleId>
            <ArticleId IdType="pmc">PMC8318629</ArticleId>
            <ArticleId IdType="pubmed">34321077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kincaid K.J., Simpkins A.N. Failure of anticoagulation to prevent stroke in context of lupus-associated anti-phospholipid syndrome and mild COVID-19. J. Stroke Cerebrovasc. Dis. 2021;30(7) doi: 10.1016/j.jstrokecerebrovasdis.2021.105817. Jul. Epub 2021 Apr 12. PMID: 33933349; PMCID: PMC8041145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2021.105817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smeele H.T., Perez-Garcia L.F., Grimminck K., Schoenmakers S., Mulders A.G., Dolhain R.J. Systemic lupus erythematosus and COVID-19 during pregnancy. Lupus. 2021;30(7):1188–1191. doi: 10.1177/09612033211002270. Jun. Epub 2021 Mar 14. PMID: 33715506; PMCID: PMC8120627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/09612033211002270</ArticleId>
            <ArticleId IdType="pmc">PMC8120627</ArticleId>
            <ArticleId IdType="pubmed">33715506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gracia-Ramos A.E., Saavedra-Salinas M.Á. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol. Int. 2021;41(4):799–809. doi: 10.1007/s00296-021-04794-7. Apr. Epub 2021 Feb 4. PMID: 33543338; PMCID: PMC7861004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-021-04794-7</ArticleId>
            <ArticleId IdType="pmc">PMC7861004</ArticleId>
            <ArticleId IdType="pubmed">33543338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plotz B., Castillo R., Melamed J., Magro C., Rosenthal P., Belmont H.M. Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Rheumatology. 2021;60(2):e61–e63. doi: 10.1093/rheumatology/keaa627. Feb 1. Erratum in: Rheumatology (Oxford). 2021 Jul 1;60(7):3485. PMID: 33147605; PMCID: PMC7665776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/keaa627</ArticleId>
            <ArticleId IdType="pmc">PMC7665776</ArticleId>
            <ArticleId IdType="pubmed">33147605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamani B., Moeini Taba S.M., Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J. Med. Case Rep. 2021;15(1):29. doi: 10.1186/s13256-020-02582-8. Ja 25. PMID: 33494816; PMCID: PMC7832415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13256-020-02582-8</ArticleId>
            <ArticleId IdType="pmc">PMC7832415</ArticleId>
            <ArticleId IdType="pubmed">33494816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Domínguez-Rojas J., Atamari-Anahui N., Chonlon-Murillo K., Tello M., Coronado-Muñoz Á. Systemic lupus erythematosus complicated with macrophage activation syndrome mimicking COVID-19 multisystemic inflammatory syndrome in children. Bol. Med. Hosp. Infant. Mex. 2021;78(6):642–646. doi: 10.24875/BMHIM.21000064. English. PMID: 34934208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.24875/BMHIM.21000064</ArticleId>
            <ArticleId IdType="pubmed">34934208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kornowski Cohen M., Sheena L., Shafir Y., Yahalom V., Gafter-Gvili A., Spectre G. An early unexpected immune thrombotic thrombocytopenic purpura relapse associated with SARS-CoV-2 infection: a case report and literature review. Acta Haematol. 2021;144(6):678–682. doi: 10.1159/000514283. Epub 2021 Apr 23. PMID: 33895748; PMCID: PMC8247821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000514283</ArticleId>
            <ArticleId IdType="pmc">PMC8247821</ArticleId>
            <ArticleId IdType="pubmed">33895748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pang J.H.Q., Tang J.H., Eugene-Fan B., Lee C.L., Low J.K. A peculiar case of small bowel stricture in a coronavirus disease 2019 patient with congenital adhesion band and superior mesenteric vein thrombosis. Ann. Vasc. Surg. 2021;70:286–289. doi: 10.1016/j.avsg.2020.08.084. Jan. Epub 2020 Aug 28. PMID: 32861849; PMCID: PMC7453213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.avsg.2020.08.084</ArticleId>
            <ArticleId IdType="pmc">PMC7453213</ArticleId>
            <ArticleId IdType="pubmed">32861849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghafouri S., Rettig M., Kahlon K.S. An 89-year-old man with COVID-19-associated coagulopathy presenting with a prolonged partial thromboplastin time, lupus anticoagulant, and a high titer of factor VIII Inhibitor. Am J Case Rep. 2020;21 doi: 10.12659/AJCR.926728. Oct 30. PMID: 33122620; PMCID: PMC7610155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/AJCR.926728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kornowski Cohen M., Sheena L., Shafir Y., Yahalom V., Gafter-Gvili A., Spectre G. An early unexpected immune thrombotic thrombocytopenic purpura relapse associated with SARS-CoV-2 infection: a case report and literature review. Acta Haematol. 2021;144(6):678–682. doi: 10.1159/000514283. Epub 2021 Apr 23. PMID:33895748; PMCID: PMC8247821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000514283</ArticleId>
            <ArticleId IdType="pmc">PMC8247821</ArticleId>
            <ArticleId IdType="pubmed">33895748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guven F., Ogul H., Turgut A., Tezcan A., Kantarci M. Leptomeningeal involvement in a patient with systemic lupus erythematosus infected by COVID-19. Joint Bone Spine. 2020;87(5):495. doi: 10.1016/j.jbspin.2020.06.002. Oct. Epub 2020 Jun 10. PMID: 32534206; PMCID: PMC7286267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbspin.2020.06.002</ArticleId>
            <ArticleId IdType="pmc">PMC7286267</ArticleId>
            <ArticleId IdType="pubmed">32534206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araten D.J., Belmont H.M., Schaefer-Cutillo J., Iyengar A., Mattoo A., Reddy R. Mild clinical course of COVID-19 in 3 patients receiving therapeutic monoclonal antibodies targeting C5 complement for hematologic disorders. Am J Case Rep. 2020;21 doi: 10.12659/AJCR.927418. Sep. 12. PMID: 32917848; PMCID: PMC7508305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/AJCR.927418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonometti R., Sacchi M.C., Stobbione P., Lauritano E.C., Tamiazzo S., Marchegiani A., Novara E., Molinaro E., Benedetti I., Massone L., Bellora A., Boverio R. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur. Rev. Med. Pharmacol. Sci. 2020;24(18):9695–9697. doi: 10.26355/eurrev_202009_23060.PMID:33015814. Sep.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.26355/eurrev_202009_23060.PMID:33015814</ArticleId>
            <ArticleId IdType="pubmed">33015814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He F., Luo Q., Lei M., Fan L., Shao X., Hu K., Qin S., Yu N., Cao J., Yang L. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin. Rheumatol. 2020;39(9):2803–2810. doi: 10.1007/s10067-020-05230-0. Sep. Epub 2020 Jul 28. PMID: 32725351; PMCID: PMC7385201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-020-05230-0</ArticleId>
            <ArticleId IdType="pmc">PMC7385201</ArticleId>
            <ArticleId IdType="pubmed">32725351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani Cardoso E., Hundal J., Feterman D., Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin. Rheumatol. 2020;39(9):2811–2815. doi: 10.1007/s10067-020-05310-1. Sep. Epub 2020 Jul 28. PMID: 32720260; PMCID: PMC7384868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-020-05310-1</ArticleId>
            <ArticleId IdType="pmc">PMC7384868</ArticleId>
            <ArticleId IdType="pubmed">32720260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gemcioglu E., Erden A., Davutoglu M., Karabuga B., Kucuksahin O. Acute Ischemic stroke in a lupus anticoagulant-positive Woman with COVID-19. J. Clin. Rheumatol. 2020;26(6):236–237. doi: 10.1097/RHU.0000000000001565. Sep. PMID: 32694351; PMCID: PMC7437427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000001565</ArticleId>
            <ArticleId IdType="pmc">PMC7437427</ArticleId>
            <ArticleId IdType="pubmed">32694351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yarlagadda K., Mi K., Sendil S., Koons C.L., Komanduri S., Cinicola J.T. A 31-year- old man with COVID-19-associated empyema and lupus anticoagulant. Am J Case Rep. 2020;21 doi: 10.12659/AJCR.926623. Aug 18. PMID: 32807764; PMCID: PMC7458696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/AJCR.926623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho J., Kandane-Rathnayake R., Louthrenoo W., Hoi A., Golder V., Chen Y.H., Luo S.F., Wu Y.J., Hamijoyo L., Lau C.S., Navarra S., Zamora L., Tee M., Flora A., Jr., Li Z.G., An Y., Sockalingam S., Katsumata Y., Harigai M., Hao Y., Zhang Z., Kikuchi J., Takeuchi T., Basnayake D., Goldblatt F., Chan M., Ng K.P.L., Bae S.C., Oon S., O'Neill S., Gibson K., Kumar S., Law A.H.N., Tugnet N., Tanaka Y., Nikpour M., Morand E., Lateef A. COVID-19 infection in patients with systemic lupus erythematosus: data from the Asia Pacific Lupus Collaboration. Int J Rheum Dis. 2020;23(9):1255–1257. doi: 10.1111/1756-185X.13937. Aug. Epub 2020 Aug 25. PMID: 32841510; PMCID: PMC7461525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1756-185X.13937</ArticleId>
            <ArticleId IdType="pmc">PMC7461525</ArticleId>
            <ArticleId IdType="pubmed">32841510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arpali E., Akyollu B., Yelken B., Tekin S., Turkmen A., Kocak B. Case report: a kidney transplant patient with mild COVID-19. Transpl. Infect. Dis. 2020;22(4) doi: 10.1111/tid.13296. Aug. Epub 2020 May 4. PMID: 32301198; PMCID: PMC7235513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/tid.13296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimminck K., Santegoets L.A.M., Siemens F.C., Fraaij P.L.A., Reiss I.K.M., Schoenmakers S. No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient. BMJ Case Rep. 2020;13(6) doi: 10.1136/bcr-2020-235581. Jun 30. PMID: 32606133; PMCID: PMC7358094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2020-235581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kichloo A., Aljadah M., Albosta M., Wani F., Singh J., Solanki S. COVID-19 and acute lupus pneumonitis: diagnostic and treatment dilemma. J Investig Med High Impact Case Rep. 2020;8 doi: 10.1177/2324709620933438. Jan-Dec. PMID: 32500773; PMCID: PMC7277418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2324709620933438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arora G., Kassir M., Jafferany M., et al.  The COVID-19 outbreak and rheumatologic skin diseases. Dermatol. Ther. 2020;33(4) doi: 10.1111/dth.13357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dth.13357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramirez G., Gerosa M., Beretta L., Bellocchi C., Argolini L., Moroni L., Della Torre E., Artusi C., Nicolosi S., Caporali R., Bozzolo E., Dagna L. COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients. Semin. Arthritis Rheum. 2020;50(5):1150–1157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7836639</ArticleId>
            <ArticleId IdType="pubmed">32927376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pablos J.L., Galindo M., Carmona L. RIER Investigators Group, et alClinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort studyAnnals of the. Rheumatic Diseases. 2020;79:1544–1549.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen C., Yao B., Yan M., Su K., Wang H., Xu C. The plight of patients with lupus nephritis during the outbreak of COVID-19 in Wuhan, China. J. Rheumatol. 2020;47(9) 1452.2-1452.</Citation>
        </Reference>
        <Reference>
          <Citation>Favalli E.G., Gerosa M., Murgo A., et al.  alAre patients with systemic lupus erythematosus at increased risk for COVID-19? Ann. Rheum. Dis. 2021;80:e25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32451344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NYU Langone News  Studies show similar COVID-19 risk factors for patients with lupus or inflammatory arthritis as general population. 2022. https://nyulangone.org/news/studies-show-similar-covid-19-risk-factors-patients-lupus-or-inflammatory-arthritis-general-population [online] Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Ye C., et al.  Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann. Rheum. Dis. 2020;79:1007–1013. doi: 10.1136/annrheumdis-2020-217627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-217627</ArticleId>
            <ArticleId IdType="pmc">PMC7295865</ArticleId>
            <ArticleId IdType="pubmed">32444415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavala-Miranda M., González-Ibarra S., Pérez-Arias A., Uribe-Uribe N., Mejia-Vilet J. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination. Kidney Int. 2021;100(6):1340–1341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8455236</ArticleId>
            <ArticleId IdType="pubmed">34560139</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
